Example: A Neuralzeta patient in 2016, 2020, 2024 and 2025

Images appear with the consent of the patient
She is an identical triplet who lost her mother and both siblings to ALS/MND within 18 months of onset.
Her family history appears below these images.

Clockwise images appearing below: Years 2016,   2020,    2024  and 2025

Neuralzeta patient 8 years of treatment

The above identical triplet
(Triplet No. 3)
Her family history chart

Her mother and two siblings all died from ALS within 18 months of onset.

It can be seen that after 9 years on Neuralzeta, she continues to be stable and active.

The identical triplets

The triplet on the right takes Neuralzeta and after 9 years is still well and active

Her mother and both her identical sisters died within 18 months of ALS onset

 What happens if Neuralzeta is withdrawn?

Triplet No. 3

.

.

What happens if Neuralzeta is withdrawn?
Neuralzeta patient 8 years of treatment

The independent drug data harvesting platform Patients Like Me (PLM) 2021

The perceived efficacy of Neuralzeta as "Major" is 89%

(Data courtesy of United Healthcare Alliance)

In 2021 the FDA in the US awarded this drug Orphan Drug Designation

Proof of MOA: In Vitro ELISA assay

Important information

The RC Charity  has no connection with any other entity, charity or corporate, and has no external financial support. Privately funded by three persons and run by a voluntary unpaid trustee. Grapl has supported us in providing training in regulatory software.
As the public nor any ALS victim have ever been asked for money and nobody gets paid, there is no requirement to register ​​the charity and incur the associated administrative costs (Registration, paid trustees, auditing etc.).

The humanitarian objective is to bring a potentially new horizon to those affected by ALS (also known as MND) - irrespective of their financial status. Provided free of any charge on first come first served basis (when funds are available) to any ALS/MND victim who asks for help, has a confirmed diagnosis, informed consent, credible case history and a valid prescription.

As more than 13 years of clinical data are covered in this site, precise statistics vary at different times.
The charity states the factual data believed to be true and accurate as reported by patients - observed by their neurologists, in their monthly monitoring reports. The charity makes no claims, only presents the reported efficacy evidence. 
Web sites cost money to optimise. This web site is not intended to be viewed on mobile devices.
NOTE: Nothing in this web site may be considered to be medical advice. You must always consult with your neurologist or doctor.
Web site last updated March 2025. © RC Charity 2012 - 2025.